A clinical feasibility study was conducted by Pulse Biosciences in Naples, Italy.
2 reports, 2 independent
Updated Aug 28
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A clinical feasibility study was conducted by Pulse Biosciences in Naples, Italy.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Pulse Biosciences conducted a clinical feasibility study in Naples.1 source
Professor Stefano Spiezia, Chief of Endocrine Surgery, was involved in the study.1 source
Keep exploring
The entities involved
Coverage
Newest first; wire copies grouped- ZacksPLSE Shares Rise on First-in-Human Data for Thyroid Nodule Treatment Pulse Biosciences PLSE has announced the publication of its first-in-human clinical feasibility study in the Journal Thyroid, high
- Business WirePulse Biosciences Announces Publication of First-In-Human Data for Treatment of Benign Thyroid Nodules in the Journal Thyroid First-in-Human Clinical Feasibility Study Demonstrates Effectiveness of A